Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Jerkeman, Mats" or (type any "bookEditor issueEditor" and editor="Jerkeman, Mats") Add to list Journal Article A1 open access Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study Martin Dreyling, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Marek Trneny, Fritz Offner (UGent) , Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, et al. (2016) LANCET. 387(10020). p.770-778 Add to list Conference Paper C3 Ibrutinib vs temsirolimus: results from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma (MCL) Simon Rule, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci, Chiara Rusconi, Marek Trneny, Fritz Offner (UGent) , Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, et al. (2015) BLOOD. 126(23).